628
Views
9
CrossRef citations to date
0
Altmetric
Original Article

In vivo experimental approach to treatment against tabun poisoning

, , , , &
Pages 531-536 | Received 17 Jul 2009, Accepted 22 Sep 2009, Published online: 17 Mar 2010

References

  • Macilwain C. Study proves Iraq used nerve gas. Nature 1993;363:3.
  • Nagao M, Takatori T, Matsuda Y, Nakajima M, Iwase H, Iwadate K. Definitive evidence for the acute sarin poisoning diagnosis in the Tokyo subway. Toxicol Appl Pharmacol 1997;144:198–203.
  • Taylor P. Anticholinesterase agents. In: Hardman LELJG, Gilman AG, eds. The Pharmacological Basis of Therapeutics. New York: McGraw-Hill, 2001:175–97.
  • Moore DH, Saunders-Price BB. Pharmaceutical countermeasures to chemical warfare agents. ASA Newslett 2, 2005;1:27–9; http://www.asanltr.com/newsletter/05-2/articles/052c.htm.
  • Eto M. Organophosphorus Pesticides: Organic and Biological Chemistry. Cleveland, OH: CRC Press, 1976:142.
  • Maksimović M, Bošković B, Radović L, Tadić V, Deljac V, Binenfeld Z. Antidotal effects of bis-pyridinium-2-monooxime carbonyl derivatives in intoxications with highly toxic organophosphorus compounds. Acta Pharm Jugoslav 1980;30:151–60.
  • Dawson RM. Review of oximes available for the treatment of nerve agent poisoning. J Appl Toxicol 1994;14:317–31.
  • Jokanović M, Maksimović M, Kilibarda V, Jovanović D, Savić D. Oxime-induced reactivation of acetylcholinesterase inhibited by phosphoramidates. Toxicol Lett 1996;85:35–9.
  • Clement JG, Shiloff JD, Gennings C. Efficacy of a combination of acetylcholinesterase reactivators, HI-6 and obidoxime against tabun and soman poisoning of mice. Arch Toxicol 1987;61:70–5.
  • Thiermann H, Szinicz L, Eyer P, Felgenhauer N, Zilker T, Worek F. Lessons to be learnt from organophosphorus pesticide poisoning for the treatment of nerve agent poisoning. Toxicology 2007;233:145–54.
  • Reiner E. Inhibition of acetylcholinesterase by 4,4′-bipyridine and its effect upon phosphylation of the enzyme. Croat Chem Acta 1986;59:925–31.
  • Simeon-Rudolf V, Reiner E, Škrinjarić-Špoljar M, Radić B, Lucić A, Primožič I, et al. Quinuclidinium-imidazolium compounds: synthesis, mode of interaction with acetylcholinesterase and effect upon soman intoxicated mice. Arch Toxicol 1998;72:289–95.
  • Čalić M, Lucić Vrdoljak A, Radić B, Jelić D, Jun D, Kuča K, et al. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity. Toxicology 2006;219:85–96.
  • Lucić Vrdoljak A, Čalić M, Radić B, Berend S, Jun D, Kuča K, et al. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning. Toxicology 2006;228:41–50.
  • Berend S, Lucić Vrdoljak A, Radić B, Kuča K. New bispyridinium oximes: in vitro and in vivo evaluation of their biological efficency in soman and tabun poisoning. Chem Biol Interact 2008;175:413–16.
  • Kovarik Z, Čalić M, Šinko G, Bosak A, Berend S, Lucić Vrdoljak A, et al. Oximes: reactivators of phosphorylated acetylcholinesterase and antidotes in therapy against tabun poisoning. Chem Biol Interact 2008;175:173–9.
  • Kovarik Z, Lucić Vrdoljak A, Berend S, Čalić M, Kuča K, Musilek K, et al. Evaluation of oxime K203 as antidote in tabun poisoning. Arh Hig Rada Toksikol 2009; 60:19–25.
  • Anderson DR, Harris LW, Woodard CL, Lennox WI. The effect of pyridostigmine pretreatment on oxime efficacy against intoxication by soman or VX in rats. Drug Chem Toxicol 1992;15:285–92.
  • Kassa J, Vachek J. A comparison of the efficacy of pyridostigmine alone and the combination of pyridostigmine with anticholinergic drugs as pharmacological pretreatment of tabun-poisoned rats and mice. Toxicology 2002;177:179–85.
  • Vachek J, Kassa J, Fusek J, Bajgar J. The present possibilities of the treatment of poisonings with organophosphates. Sbor věd Prací VLA JEP Hradec Králové 1993;116:67–95.
  • Bajgar J. Prophylaxis against organophosphorus poisoning. J Med Chem Def 2003;1:1–19.
  • Kuča K, Bielavsky J, Cabal J, Kassa J. Synthesis of a new reactivator of tabun-inhibited acetylcholinesterase. Bioorg Med Chem Lett 2003;13:3545–7.
  • Kuča K, Cabal J, Musilek K, Jun D, Bajgar J. Effective bisquaternary reactivators of tabun-inhibited AChE. J Appl Toxicol 2005;25;491–5.
  • Thompson WR. Use of moving averages and interpolation to estimate median-effective dose. Bacteriol Rev 1947;11:115–45.
  • Weil CS. Tables for convenient calculation of median-effective dose (LD50 or ED50) and instruction in their use. Biometrics 1952;8:249–63.
  • Ohtomi S, Takase S, Kumagai F. Sarin poisoning in Japan. A clinical experience in Japan Self Defense Force (JSDF) Central Hospital. Int Rev Armed Serv 1996;69:97–102.
  • Harris LW, McDonough JH Jr, Stitcher DL, Lennox WJ. Protection against both lethal and behavioural effects of soman. Drug Chem Toxicol 1984;7:605–24.
  • Harris LW, Heyl WC, Stitcher DL, Broomfield CA. Effects of 1,1′-oxydimethylene bis-(4-tert-butylpyridinium chloride) (SAD-128) and decamethonium on reactivation of soman- and sarin-inhibited cholinesterase by oximes. Biochem Pharmacol 1978;27:757–61.
  • Škrinjarić-Špoljar M, Burger N, Lovrić J. Inhibition of acetylcholinesterase by three new pyridinium compounds and their effect on phosphonylation of the enzyme. J Enzym Inhib 1999;14:331–41.
  • Lallement G, Baille V, Baubichon D, Carpentier P, Collombet JM, Filliat P, et al. Review of the value of huperzine as pretreatment of organophosphate poisoning. Neurotoxicology 2002;23:1–5.
  • Eckert S, Eyer P, Muckter H, Worek F. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds. Biochem Pharmacol 2006;72:344–57.
  • Dunn MA, Hackley BE, Sidell FR. Pretreatment for nerve agent exposure. In: Sidell FR, Takafuji ET, Franz DR, eds. Medical Aspects of Chemical Biological Warfare. Washington, DC: Walter Reed Army Medical Center, 1997:181–96.
  • Lenz DE, Broomfield CA, Maxwell DM, Cerasoli DM. Nerve agent bioscavengers: protection against high- and low-dose organophosphorus exposure. In: Somani SM, Romano JA Jr, eds. Chemical Warfare Agents: Toxicity at Low Levels. Boca Raton, FL: CRC Press, 2001:215–43.
  • Doctor BP, Saxena A. Bioscavengers for the protection of humans against organophosphate toxicity. Chem Biol Interact 2005;157–8:167–71.
  • Saxena A, Sun W, Luo C, Doctor BP. Human serum butyrylcholinesterase: in vitro and in vivo stability, pharmacokinetics, and safety in mice. Chem Biol Interact 2005;157–8:199–203.
  • Puu G, Artursson E, Bucht G. Reactivation of nerve agent inhibited acetylcholinesterase by HI-6 and obidoxime. Biochem Pharmacol 1986;35:1505–10.
  • Antonijević B, Bokonjić D, Stojiljković MP, Kilibarda V, Milovanović ZA, Nedeljković M, et al. Efficacy of trimedoxime in mice poisoned with dichlorvos, heptenophos or monocrotophos. Basic Clin Pharmacol Toxicol 2005;96:111–17.
  • Shih TM, Koviak TA, Capacio BR. Anticonvulsants for poisoning by the organophosphorus compound soman: pharmacological mechanisms. Neurosci Biobehav Rev 1991;15:349–62.
  • Shih TM, McDonough JH, Koplovitz I. Anticonvulsants for soman-induced seizure activity. J Biomed Sci 1999;6:86–96.
  • Petroianu GA, Hasan MY, Nurulain SM, Shafiullah M, Sheen R, Nagelkerke N. Ranitidine in acute high-dose organophosphate exposure in rats: effect of the time-point of administration and comparison with pyridostigmine. Basic Clin Pharmacol Toxicol 2006;99:312–16.
  • Thiermann H, Szinicz L, Eyer P, Felgenhauer N, Zilker T, Worek F. Lessons to be learnt from organophosphorus pesticide poisoning for the treatment of nerve agent poisoning. Toxicology 2007;233:145–54.
  • Kuča K, Bartošová L, Jun D, Patočka J, Cabal J, Kassa J, et al. New quaternary pyridine aldoximes as causal antidotes against nerve agents intoxications. Biomed Papers 2005;149:75–82.
  • Golomb BA, Anthony CR. A review of the scientific literature as it pertains to Gulf War ilness: pyridostigmine bromide. RAND Health Testimony. Santa Monica, CA: RAND Health, 1999.
  • Koplovitz I, Harris LW, Anderson DR, Lennox WJ, Stewart JR. Reduction by pyridostigmine pretreatment of the efficacy of atropine and 2-PAM treatment of sarin and VX poisoning in rodents. Fundam Appl Toxicol 1992;18:102–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.